Jefferies analyst Stephen Barker downgraded Kissei Pharmaceutical to Hold from Buy with a price target of 3,400 yen, up from 3,300 yen. The analyst cites valuation for the downgrade following the recent rally in the shares.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>